EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transplantation of mesenchymal stromal cell-derived mitochondria alleviates endothelial dysfunction in pre-clinical models of acute respiratory distress syndrome

Dayene de Assis Fernandes Caldeira, Johnatas Dutra Silva, Monique Martins Melo, Rodrigo Gonzaga Veras, Daniel F McAuley, Patricia Rieken Macedo Rocco, Pedro Leme Silva, Fernanda Ferreira Cruz iD, Anna Krasnodembskaya iD

Stem Cells Translational Medicine · 14.11.2025 · 14 (11)

DOI: 10.1093/stcltm/szaf053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cells Translational Medicine, online erschienen am 15.11.2025. Verfasst von Dayene de Assis Fernandes Caldeira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast BT9…. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Mesenchymal Stem Cells, Mitochondria, Endothelial Cells. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UK Medical Research Council Research, Brazilian Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulmonary endothelial dysfunction with increased capillary permeability is a key aspect in the pathogenesis of acute respiratory distress syndrome (ARDS). It has been demonstrated that mesenchymal stromal cells (MSC) can modulate host cells through mitochondrial transfer. Although mitochondrial transplantation is a promising treatment strategy for conditions underpinned by mitochondrial dysfunction, its therapeutic potential in ARDS has not been sufficiently investigated. Herein, we tested the potential of MSC mitochondrial transplantation to restore functionality of the pulmonary endothelium in pre-clinical models of ARDS.

Methods

Mitochondria (mt) derived from human bone-marrow MSC were isolated and immediately used for transplantation to primary human pulmonary microvascular endothelial cells (HPMEC) in the presence of Escherichia coli lipopolysaccharide (LPS) or plasma samples from ARDS patients classified into hypo- and hyper-inflammatory phenotypes. Mitochondrial function, inflammatory status, and barrier integrity of HPMEC were assessed at 24 h. LPS- challenged mice were treated with MSC-mt intravenously, and the severity of lung injury and inflammatory response were evaluated.

Results

Exposure to LPS or ARDS plasma induced endothelial hyperpermeability associated with mitochondrial dysfunction. MSC-mt were readily internalized by HPMEC without cytotoxicity or inflammatory response, mitigating mitochondrial dysfunction and restoring barrier integrity. In vivo, administration of MSC-mt alleviated lung injury, reduced inflammatory cell infiltration in the alveoli and increased VE-cadherin mRNA levels in the lung tissue, indicating restoration of the alveolar-capillary barrier integrity.

Conclusion

This study demonstrated MSC mitochondrial transplantation as a promising therapeutic approach for treatment of endothelial dysfunction in the context of acute inflammation. Further exploration of mitochondrial transplantation in ARDS is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Distress SyndromeMesenchymal Stem CellsMitochondriaEndothelial CellsMesenchymal Stem Cell TransplantationAnimalsHumansDisease Models, AnimalMiceLipopolysaccharidesMaleCapillary PermeabilityMice, Inbred C57BLLungFemaleCells, CulturedAntigens, CDCadherinsCadherin 5

Stichwörter der Autor:innen

acute respiratory distress syndromemesenchymal stromal cellsmitochondrial dysfunctionmitochondrial transplantationpulmonary endothelial barrier

Substanzen

LipopolysaccharidesAntigens, CDCadherinsCadherin 5

Autor:innen und Institutionen

  • Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast BT9 7BL, United Kingdom.
  • Laboratory of Pulmonary Investigation, Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro, Rio de Janeiro CEP: 21941-902, Brazil.
  • National Institute of Science and Technology for Regenerative Medicine, Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID-Profile: Fernanda Ferreira Cruz, Anna Krasnodembskaya

Förderung

  • UK Medical Research Council Research
  • Brazilian Council for Scientific and Technological Development

Zitieren

APA

de Assis Fernandes Caldeira, D., Dutra Silva, J., Martins Melo, M., Gonzaga Veras, R., McAuley, D. F., Rieken Macedo Rocco, P., Silva, P. L., Cruz, F. F., & Krasnodembskaya, A. (2025). Transplantation of mesenchymal stromal cell-derived mitochondria alleviates endothelial dysfunction in pre-clinical models of acute respiratory distress syndrome. Stem Cells Translational Medicine, 14(11). https://doi.org/10.1093/stcltm/szaf053

Vancouver

de Assis Fernandes Caldeira D, Dutra Silva J, Martins Melo M, Gonzaga Veras R, McAuley DF, Rieken Macedo Rocco P, et al. Transplantation of mesenchymal stromal cell-derived mitochondria alleviates endothelial dysfunction in pre-clinical models of acute respiratory distress syndrome. Stem Cells Translational Medicine. 2025;14(11). doi:10.1093/stcltm/szaf053

BibTeX
@article{deAssisFernandesCaldeira2025,
  author = {de Assis Fernandes Caldeira, Dayene and Dutra Silva, Johnatas and Martins Melo, Monique and Gonzaga Veras, Rodrigo and McAuley, Daniel F and Rieken Macedo Rocco, Patricia and Silva, Pedro Leme and Cruz, Fernanda Ferreira and Krasnodembskaya, Anna},
  title = {Transplantation of mesenchymal stromal cell-derived mitochondria alleviates endothelial dysfunction in pre-clinical models of acute respiratory distress syndrome},
  journal = {Stem Cells Translational Medicine},
  year = {2025},
  volume = {14},
  number = {11},
  doi = {10.1093/stcltm/szaf053}
}
Kostenlos starten →